Oxford Genetics to Distribute CLS Cell Lines Service Products
The worldwide distribution agreement expands Oxford's existing product and service portfolio, streamlining workflows for current customers, the company said.
Gene Drives Ahead
The UN Convention on Biodiversity has rejected a moratorium on gene drives, Nature News says.
Eurofins Opens Up Early Access Program for New DNA Synthesis Platform
The company is hoping to find a niche among customers who want the quality of high-throughput oligonucleotide synthesis but smaller order volumes.
Strategy Session Urged
The President's Council of Advisors on Science and Technology urges the adoption of a biodefense strategy, Tech Review reports.
Oxford Genetics Receives £1M Investment
The company said it would use the funding to continue licensing its DNA design technology in the cell and gene therapy markets.
UK Opening Five New DNA Synthesis Foundries to Support National Research
The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.
This Week in Science: Aug 19, 2016
In Science this week: effort to reduce E. coli genome, and more.
From Undergrad Job to Minimal Genomes
The Scientist traces the career path of the J. Craig Venter Institute's Clyde Hutchinson.
Synthorx Nabs $10M in Series B Financing
The firm is developing protein therapies incorporating synthetic amino acids coded for by "unnatural" base pairs developed at The Scripps Research Institute.
Ginkgo Bioworks Raises $100M in Series C Funding Round
The company said it will use the proceeds to fund its growth into new markets, and to build its next-generation automated foundry.